Vaxcyte Inc (PCVX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2019 | 12-2018 | 12-2017 | 12-2006 | |
| Cash Flows From Operating Activities | ||||
| Net Income | -50,274 | -29,485 | N/A | N/A |
| Depreciation Amortization | 1,232 | 1,037 | N/A | N/A |
| Accounts payable and accrued liabilities | 868 | 1,266 | N/A | N/A |
| Other Working Capital | 3,908 | 1,895 | N/A | N/A |
| Other Operating Activity | -2,879 | -5,179 | 0 | 0 |
| Operating Cash Flow | $-47,145 | $-30,466 | $N/A | $N/A |
| Cash Flows From Investing Activities | ||||
| PPE Investments | -1,195 | -1,773 | N/A | N/A |
| Investing Cash Flow | $-1,195 | $-1,773 | $N/A | $N/A |
| Cash Flows From Financing Activities | ||||
| Debt Repayment | -278 | -283 | N/A | N/A |
| Common Stock Issued | 442 | 128 | N/A | N/A |
| Other Financing Activity | 41,403 | 62,345 | 0 | 0 |
| Financing Cash Flow | $41,567 | $62,190 | $N/A | $N/A |
| Exchange Rate Effect | -341 | N/A | N/A | N/A |
| Beginning Cash Position | 66,090 | 36,139 | N/A | N/A |
| End Cash Position | 58,976 | 66,090 | N/A | N/A |
| Net Cash Flow | $-7,114 | $29,951 | $N/A | $N/A |
| Free Cash Flow | ||||
| Operating Cash Flow | -47,145 | -30,466 | N/A | N/A |
| Capital Expenditure | -1,195 | -1,774 | N/A | N/A |
| Free Cash Flow | -48,340 | -32,240 | 0 | 0 |